ArticleBMC psychiatry2026
Sertraline and quetiapine induced Serotonin Syndrome and Neuroleptic Malignant Syndrome: a case report.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuroleptic malignant syndrome precipitated by chlorpromazine: a case report.Journal of medical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSerotonin Syndrome (SS) and Neuroleptic Malignant Syndrome (NMS) are more likely to occur in psychiatric patients. Both conditions have a low incidence rate but can be life-threatening in severe cases.they are easily overlooked, misdiagnosed, or missed in clinical practice. CASE PRESENTATION: A case of a girl who ingested 700 mg of sertraline,350 mg of quetiapine and 90 mg of oxazepam, presenting with altered consciousness, hallucinations, muscle rigidity, and rhabdomyolysis. Laboratory results showed a creatine phosphokinase (CPK) concentration of 20,930 U/L, lactate dehydrogenase (LDH) of 593 U/L, and white blood cell (WBC) count of 15.1 × 10^9/L. The patient met the diagnostic criteria for both Serotonin Syndrome and Neuroleptic Malignant Syndrome, possibly exhibiting both adverse drug reactions closely spaced. Treatment involved discontinuing the implicated drugs, providing tracheal intubation, ventilatory support, continuous renal replacement therapy (CRRT), cardiac protection, anti-inflammatory treatment, norepinephrine to maintain blood pressure, and other treatments to support organ function. The patient recovered after one month.
conclusionsThis article analyzes the clinical data and reviews the literature to discuss the management of severe complications caused by antipsychotic drugs and antidepressant drugs, aimed to improve awareness of these two adverse reactions. Guardians should strictly monitor the patient’s medication usage to prevent the child from freely accessing medications, thereby avoiding self-medication or overdose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.